Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2013 04:01 ET | Source: RaySearch Laboratories AB

First RayStation® order in Scandinavia

RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from Oslo University Hospital in Oslo, Norway. Oslo University Hospital is a highly specialized public...
October 02, 2013 01:30 ET | Source: Elekta AB

Nucletron, an Elekta Company, Receives US FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin Cancer

Stockholm, October 2 – Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the US Food and Drug Administration (FDA), enabling medical centers in the United States to offer...
September 21, 2013 12:00 ET | Source: Elekta AB

Elekta lanserar Esteya – elektronisk brachyterapi för behandling av hudcancer

Stockholm, 21 september – Nucletron, ett Elektaföretag världsledande inom brachyterapi, lanserar Esteya®, en ny behandlingsmetod för patienter med hudcancer. Under de senaste 30 åren har antalet fall...
September 21, 2013 12:00 ET | Source: Elekta AB

Nucletron, an Elekta Company, Introduces Esteya, Electronic Brachytherapy for Treating Skin Cancer

ATLANTA, Sept. 21 – Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer. Over the last 30 years, more...
August 28, 2013 01:45 ET | Source: RaySearch Laboratories AB

RaySearch Laboratories AB (publ) Delårsrapport 1 januari – 30 juni 2013

1 JANUARI – 30 JUNI 2013 · Nettoomsättningen för perioden uppgick till 75,4 (65,0) MSEK · Resultatet efter skatt uppgick till -10,8 (-4,0) MSEK och resultatet per aktie till -0,32 (-0,12) SEK ·...
August 28, 2013 01:45 ET | Source: RaySearch Laboratories AB

RaySearch Laboratories AB (publ) Interim Report January 1 – June 30, 2013

JANUARY 1 – JUNE 30, 2013 · Net sales for the period amounted to SEK 75.4 M (65.0) · A loss after tax of SEK 10.8 M (loss: 4.0) was reported and the loss per share was SEK 0.32 (loss: 0.04) ·...
August 26, 2013 09:44 ET | Source: RaySearch Laboratories AB

Första kinesiska ordern på RayStation®

RaySearch Laboratories AB (publ.) erhöll i juli regulatoriskt marknadsgodkännande av RaySearchs dosplaneringssystem RayStation® från den kinesiska läkemedelsmyndigheten CFDA och idag fick RaySearch...
August 26, 2013 09:44 ET | Source: RaySearch Laboratories AB

First RayStation® order in China

RaySearch Laboratories AB received regulatory market approval in July by the Chinese regulatory agency CFDA for RaySearch’s treatment planning system RayStation® and today RaySearch received the first...
August 23, 2013 09:58 ET | Source: RaySearch Laboratories AB

Provision Center for Proton Therapy väljer RayStation®

RaySearch Laboratories AB (publ.) har erhållit en order på dosplaneringssystemet RayStation® från Provision Center for Proton Therapy. Ordern från Provision är en viktig milstolpe eftersom det är det...
August 23, 2013 09:58 ET | Source: RaySearch Laboratories AB

Provision Center for proton therapy selects RayStation®

RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from Provision Center for Proton Therapy. This partnership with Provision represents a milestone since it...